Quinn Tays (he/him/his)

MSc Candidate
University of Manitoba
Winnipeg, Manitoba, Canada

Quinn Tays is an MSc candidate in the College of Pharmacy at the University of Manitoba and has a BSc Honours in chemistry with a focus on biopharmaceuticals. His master’s thesis aims to explore the impact of drug type, symptom duration and the impact of transitions of disease state in relation to the effect of therapeutic-dose heparin in patients with COVID-19.

Presentation(s):

• OC 05.2 - Impact of heparin on disease state transition in hospitalized, non-critically ill patients with COVID-19; secondary analysis of an international multi-platform RCT

  Saturday, June 24, 2023
  13:15 – 13:30 ET

• OC 29.4 - Impact of symptom duration on clinical outcomes in hospitalized, non-critically ill patients with COVID-19; secondary analysis of an international multi-platform RCT

  Sunday, June 25, 2023
  15:30 – 15:45 ET

• PB0052 - Heparin type & clinical outcomes in hospitalized, non-critically ill patients with COVID-19: secondary analysis of an international multi-platform RCT

  Sunday, June 25, 2023
  18:30 – 19:30 ET